Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT03635151
Eligibility Criteria:
Inclusion Criteria:
* 21 years or older
* Primary caregiver (unpaid family member or significant other providing care for a stroke survivor)
* Must be providing care after discharge to the home setting (for Specific Aim 2)
* Fluent in the English language
* Access to telephone or computer
* No difficulties hearing or talking by telephone or computer
* (Specific Aim 1) Willing to participate in an online or telephone focus group or an online or telephone individual interview. Some interviews or focus groups may be offered face to face.
* (Specific Aim 2) Willing to participate in 9 calls from a nurse and 3 data collection interviews.
Exclusion Criteria:
Excluded if the survivor:
* Had not had a stroke
* Did not need help from the caregiver
* Was going to reside in a nursing home or long-term care facility
Excluded if the caregiver:
* Scores \<16 on the Oberst Caregiving Burden Scale Task Difficulty Subscale (for Specific Aim 2)
* Scores \< 4 on a 6-item cognitive impairment screener.
Excluded if the caregiver or survivor is:
* Prisoner or on house arrest
* Pregnant
* Terminal illness (e.g., late stage cancer, end-of-life condition, renal failure requiring dialysis)
* History of Alzheimer's, dementia, or severe mental illness (e.g., suicidal tendencies, schizophrenia, severe untreated depression or manic depressive disorder)
* History of hospitalization for alcohol or drug abuse
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT03635151
Study Brief:
Protocol Section:
NCT03635151